US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Latest News about XNAS:CNTX

Recent news which mentions XNAS:CNTX

Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
Tickers CNTX
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
Tags Context Therapeutics XNAS:CNTX
From TheNewswire.com - RSS (Media)
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)